Open Access

Ursolic acid suppresses the invasive potential of colorectal cancer cells by regulating the TGF‑β1/ZEB1/miR‑200c signaling pathway

  • Authors:
    • Ling Zhang
    • Qiao‑Yan Cai
    • Jianxin Liu
    • Jun Peng
    • You‑Qin Chen
    • Thomas J. Sferra
    • Jiu‑Mao Lin
  • View Affiliations

  • Published online on: July 11, 2019     https://doi.org/10.3892/ol.2019.10604
  • Pages: 3274-3282
  • Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Ursolic acid (UA) is a biologically active compound, commonly used in traditional Chinese medicine (TCM). It has been reported to exhibit strong anticancer properties against a variety of cancers. Our previous studies showed that UA promoted apoptosis in colorectal cancer (CRC) cells and inhibited cellular proliferation and angiogenesis. However, the effect and underlying molecular mechanism of UA in CRC progression remain unclear. In the present study, the role of UA in suppressing the migration and invasion of human colon cancer HCT116 and HCT‑8 cells was investigated, using Transwell assays. In addition, to evaluate whether the anticancer properties of UA were mediated by the regulation of a double‑negative feedback loop consisting of the transforming growth factor‑β1 (TGF‑β1)/zinc finger E‑box‑binding homeobox (ZEB1) pathway and microRNA (miR)‑200a/b/c, reverse transcription‑quantitative PCR and western blot analysis were performed. The results indicated that UA treatment significantly suppressed cellular growth, migration and invasion in HCT116 and HCT‑8 cells in a dose‑dependent manner. Furthermore, following UA treatment, several crucial mediators of the TGF‑β1 signaling pathway, including TGF‑β1, phosphorylated (p)‑Smad2/3, p‑focal adhesion kinase and ZEB1, were significantly downregulated in the HCT116 and HCT‑8 cell lines compared with the control group. Furthermore, the ratio of N‑cadherin/E‑cadherin, two proteins directly downstream of the TGF‑β1 signaling pathway, was found to be downregulated in UA treated CRC cells. Finally, UA significantly upregulated miR200a/b/c, with miR‑200c exhibiting the highest increase in expression levels following UA treatment. Collectively, the present study suggested that inhibition of CRC cell invasion by UA occurred via regulation of the TGF‑β1/ZEB1/miR‑200c signaling network, which may be one of the mechanisms by which UA appears to be an effective therapeutic agent against colon cancer.
View Figures
View References

Related Articles

Journal Cover

September 2019
Volume 18 Issue 3

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Zhang, L., Cai, Q., Liu, J., Peng, J., Chen, Y., Sferra, T.J., & Lin, J. (2019). Ursolic acid suppresses the invasive potential of colorectal cancer cells by regulating the TGF‑β1/ZEB1/miR‑200c signaling pathway. Oncology Letters, 18, 3274-3282. https://doi.org/10.3892/ol.2019.10604
MLA
Zhang, L., Cai, Q., Liu, J., Peng, J., Chen, Y., Sferra, T. J., Lin, J."Ursolic acid suppresses the invasive potential of colorectal cancer cells by regulating the TGF‑β1/ZEB1/miR‑200c signaling pathway". Oncology Letters 18.3 (2019): 3274-3282.
Chicago
Zhang, L., Cai, Q., Liu, J., Peng, J., Chen, Y., Sferra, T. J., Lin, J."Ursolic acid suppresses the invasive potential of colorectal cancer cells by regulating the TGF‑β1/ZEB1/miR‑200c signaling pathway". Oncology Letters 18, no. 3 (2019): 3274-3282. https://doi.org/10.3892/ol.2019.10604